STATE OF WISCONSIN INVESTMENT BOARD
Position in NRIX — Nurix Therapeutics, Inc.
CIK 854157
MADISON, WI
Position in NRIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$787,018
+$253,493 QoQ
Shares Held
32,441
-5.8% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#111
of 210 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STATE OF WISCONSIN INVESTMENT BOARD holds $511,704,326 across 163 Biotechnology names. NRIX ranks #113 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
135,798 | $67,454,940 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
55,287 | $34,473,655 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
70,171 | $21,123,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
83,892 | $15,711,293 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
248,821 | $15,018,835 | |
| 6 | MRNA |
Moderna, Inc.
|
207,705 | $14,545,581 | |
| 7 | INSM |
INSMED Inc
|
118,057 | $12,587,237 | |
| 8 | RPRX |
Royalty Pharma plc
|
213,373 | $11,963,824 |
All Filings in NRIX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $787,018 | 32,441 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $533,525 | 34,421 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $635,779 | 33,515 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $367,363 | 39,758 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,063,826 | 93,400 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,121,424 | 94,396 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $944,373 | 50,126 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $833,547 | 37,096 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $733,330 | 35,138 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $246,555 | 23,891 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $217,313 | 27,648 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $279,690 | 27,997 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $259,962 | 29,275 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $356,871 | 32,502 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $448,166 | 34,395 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $314,127 | 24,793 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $567,405 | 40,500 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,172,475 | 40,500 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,213,380 | 40,500 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,074,465 | 40,500 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $488,113 | 15,700 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $516,216 | 15,700 | Shares | Sole | 2021-02-03 | |
| No filing history on record for this holder in this stock. | ||||||